World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
24202
World Ranking
16138
National Ranking
184

Baofeng Yang publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Baofeng Yang sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 495 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Baofeng Yang D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Baofeng Yang sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Baofeng Yang is affiliated with Harbin Medical University in China. They have a robust research profile primarily focused on biochemistry, genetics, and molecular biology, with significant contributions also in medicine.

Their research spans several subfields of study, including:

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine
  • Cancer Research
  • Epidemiology
  • Surgery

Baofeng Yang's main research topics cover a variety of molecular and disease-related mechanisms, notably:

  • Cancer-related molecular mechanisms research
  • RNA modifications and cancer
  • Autophagy in Disease and Therapy
  • Cardiac Fibrosis and Remodeling
  • MicroRNA in disease regulation
  • Signaling Pathways in Disease
  • Traditional Chinese Medicine Analysis

The scientist has published extensively in frequent venues such as:

  • Engineering
  • Biomedicine & Pharmacotherapy
  • Acta Pharmacologica Sinica
  • Frontiers in Pharmacology
  • Nature Communications

Notable recent papers include:

  • Nonpharmacologic Interventions for Reducing Blood Pressure in Adults With Prehypertension to Established Hypertension, 2020, Journal of the American Heart Association
  • ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1, 2021, Theranostics
  • GDF11 inhibits cardiomyocyte pyroptosis and exerts cardioprotection in acute myocardial infarction mice by upregulation of transcription factor HOXA3, 2020, Cell Death and Disease
  • Targeting LncDACH1 promotes cardiac repair and regeneration after myocardium infarction, 2020, Cell Death and Differentiation
  • GDF11 promotes wound healing in diabetic mice via stimulating HIF-1ɑ-VEGF/SDF-1ɑ-mediated endothelial progenitor cell mobilization and neovascularization, 2022, Acta Pharmacologica Sinica

Frequent co-authors collaborating with Baofeng Yang include:

  • Yong Zhang
  • Zhenwei Pan
  • Lina Xuan
  • Benzhi Cai
  • Jinhui Wang

Best Publications

  • Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction

    Jing Ai;Rong Zhang;Yue Li;Jielin Pu

  • MicroRNA-328 Contributes to Adverse Electrical Remodeling in Atrial Fibrillation

    Yanjie Lu;Ying Zhang;Ning Wang;Zhenwei Pan

  • Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis.

    Xianxian Wu;Xianxian Wu;Haiying Zhang;Wei Qi;Ying Zhang

  • Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines

    Hongli Shan;Yong Zhang;Yanjie Lu;Ying Zhang

  • Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis.

    Yong Zhang;Yong Zhang;Xin Liu;Xue Bai;Yuan Lin

  • MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway.

    Zhenwei Pan;Xuelin Sun;Hongli Shan;Ning Wang

  • MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts.

    Jiening Xiao;Jiening Xiao;Jiening Xiao;Xiaobin Luo;Xiaobin Luo;Xiaobin Luo;Huixian Lin;Huixian Lin;Huixian Lin;Ying Zhang

  • MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation

    Xiaobin Luo;Zhenwei Pan;Hongli Shan;Jiening Xiao

  • Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4.

    Jiening Xiao;Baofeng Yang;Huixian Lin;Huixian Lin;Huixian Lin;Yanjie Lu

  • HERG K+ Channel, a Regulator of Tumor Cell Apoptosis and Proliferation

    Huizhen Wang;Yiqiang Zhang;Liwen Cao;Hong Han

  • MIAT Is a Pro-fibrotic Long Non-coding RNA Governing Cardiac Fibrosis in Post-infarct Myocardium.

    Xuefeng Qu;Yue Du;You Shu;Ming Gao

  • Down-regulation of miR-1/miR-133 Contributes to Re-expression of Pacemaker Channel Genes HCN2 and HCN4 in Hypertrophic Heart

    Xiaobin Luo;Xiaobin Luo;Huixian Lin;Zhengwei Pan;Jiening Xiao

  • Calcium and polyamine regulated calcium-sensing receptors in cardiac tissues

    Rui Wang;Changqing Xu;Weimin Zhao;Jing Zhang

  • A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference

    Yanjie Lu;Jiening Xiao;Huixian Lin;Yunlong Bai

  • MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection.

    Yanjie Lu;Yong Zhang;Hongli Shan;Zhenwei Pan

  • LncRNA ZFAS1 as a SERCA2a Inhibitor to Cause Intracellular Ca2+ Overload and Contractile Dysfunction in a Mouse Model of Myocardial Infarction.

    Ying Zhang;Lei Jiao;Lihua Sun;Yanru Li

  • Reciprocal Repression Between MicroRNA-133 and Calcineurin Regulates Cardiac Hypertrophy. A Novel Mechanism for Progressive Cardiac Hypertrophy

    De-Li Dong;Chang Chen;Rong Huo;Ning Wang

  • A novel reciprocal loop between microRNA-21 and TGFβRIII is involved in cardiac fibrosis.

    Haihai Liang;Chun Zhang;Tao Ban;Yu Liu

  • Reciprocal Changes of Circulating Long Non-Coding RNAs ZFAS1 and CDR1AS Predict Acute Myocardial Infarction

    Ying Zhang;Lihua Sun;Lina Xuan;Zhenwei Pan

  • MicroRNAs and atrial fibrillation: mechanisms and translational potential

    Xiaobin Luo;Baofeng Yang;Stanley Nattel

Frequent Co-Authors

Rui Wang
Rui Wang York University
Baoxin Li
Baoxin Li Shaanxi Normal University
Wen-Hui Wang
Wen-Hui Wang New York Medical College
Stanley Nattel
Stanley Nattel Montreal Heart Institute
Levon M. Khachigian
Levon M. Khachigian University of New South Wales
Michael S. Goligorsky
Michael S. Goligorsky New York Medical College
Steven C. Hebert
Steven C. Hebert Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring pathways in medicine beyond the traditional MD, there are several flexible online degrees and career routes to consider. For those interested in the administrative side of healthcare, pursuing an accelerated healthcare administration degree online can be a fast track to leadership roles in hospitals and clinics.

For aspiring nurses, some schools now offer nursing programs without teas, which means you can begin your education without the stress of standardized entry exams. Additionally, those who already have an Associate Degree in Nursing (ADN) and want to advance their careers can enroll in specialized adn to np bridge programs that provide a clear route to becoming a Nurse Practitioner (NP).

If you prefer working behind the scenes, there are medical billing and coding schools that accept fafsa, making this in-demand career field more accessible with financial aid support.

Each of these pathways offers flexibility, accessibility, and the chance to make a real difference in healthcare, whether you work directly with patients or support the system from an administrative or technical role.

Best Scientists Citing Baofeng Yang

Trending Scientists

Recently Published Articles